These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
562 related articles for article (PubMed ID: 27259701)
1. RNF8 promotes epithelial-mesenchymal transition of breast cancer cells. Kuang J; Li L; Guo L; Su Y; Wang Y; Xu Y; Wang X; Meng S; Lei L; Xu L; Shao G J Exp Clin Cancer Res; 2016 Jun; 35(1):88. PubMed ID: 27259701 [TBL] [Abstract][Full Text] [Related]
2. VEGF/NRP-1axis promotes progression of breast cancer via enhancement of epithelial-mesenchymal transition and activation of NF-κB and β-catenin. Luo M; Hou L; Li J; Shao S; Huang S; Meng D; Liu L; Feng L; Xia P; Qin T; Zhao X Cancer Lett; 2016 Apr; 373(1):1-11. PubMed ID: 26805761 [TBL] [Abstract][Full Text] [Related]
3. The monoamine oxidase-A inhibitor clorgyline promotes a mesenchymal-to-epithelial transition in the MDA-MB-231 breast cancer cell line. Satram-Maharaj T; Nyarko JN; Kuski K; Fehr K; Pennington PR; Truitt L; Freywald A; Lukong KE; Anderson DH; Mousseau DD Cell Signal; 2014 Dec; 26(12):2621-32. PubMed ID: 25152370 [TBL] [Abstract][Full Text] [Related]
4. Baicalein suppresses metastasis of breast cancer cells by inhibiting EMT via downregulation of SATB1 and Wnt/β-catenin pathway. Ma X; Yan W; Dai Z; Gao X; Ma Y; Xu Q; Jiang J; Zhang S Drug Des Devel Ther; 2016; 10():1419-41. PubMed ID: 27143851 [TBL] [Abstract][Full Text] [Related]
5. The DNA Damage Transducer RNF8 Facilitates Cancer Chemoresistance and Progression through Twist Activation. Lee HJ; Li CF; Ruan D; Powers S; Thompson PA; Frohman MA; Chan CH Mol Cell; 2016 Sep; 63(6):1021-33. PubMed ID: 27618486 [TBL] [Abstract][Full Text] [Related]
6. miR-214 inhibits epithelial-mesenchymal transition of breast cancer cells via downregulation of RNF8. Min L; Liu C; Kuang J; Wu X; Zhu L Acta Biochim Biophys Sin (Shanghai); 2019 Aug; 51(8):791-798. PubMed ID: 31294443 [TBL] [Abstract][Full Text] [Related]
7. Astrocyte elevated gene-1(AEG-1) induces epithelial-mesenchymal transition in lung cancer through activating Wnt/β-catenin signaling. He W; He S; Wang Z; Shen H; Fang W; Zhang Y; Qian W; Lin M; Yuan J; Wang J; Huang W; Wang L; Ke Z BMC Cancer; 2015 Mar; 15():107. PubMed ID: 25880337 [TBL] [Abstract][Full Text] [Related]
8. Taxifolin inhibits breast cancer cells proliferation, migration and invasion by promoting mesenchymal to epithelial transition via β-catenin signaling. Li J; Hu L; Zhou T; Gong X; Jiang R; Li H; Kuang G; Wan J; Li H Life Sci; 2019 Sep; 232():116617. PubMed ID: 31260685 [TBL] [Abstract][Full Text] [Related]
9. Downregulation of tumor suppressing STF cDNA 3 promotes epithelial-mesenchymal transition and tumor metastasis of osteosarcoma by the Wnt/GSK-3β/β-catenin/Snail signaling pathway. Lv YF; Dai H; Yan GN; Meng G; Zhang X; Guo QN Cancer Lett; 2016 Apr; 373(2):164-73. PubMed ID: 26845447 [TBL] [Abstract][Full Text] [Related]
10. Shikonin inhibits triple-negative breast cancer-cell metastasis by reversing the epithelial-to-mesenchymal transition via glycogen synthase kinase 3β-regulated suppression of β-catenin signaling. Chen Y; Chen ZY; Chen L; Zhang JY; Fu LY; Tao L; Zhang Y; Hu XX; Shen XC Biochem Pharmacol; 2019 Aug; 166():33-45. PubMed ID: 31071331 [TBL] [Abstract][Full Text] [Related]
11. Bmi-1 promotes invasion and metastasis, and its elevated expression is correlated with an advanced stage of breast cancer. Guo BH; Feng Y; Zhang R; Xu LH; Li MZ; Kung HF; Song LB; Zeng MS Mol Cancer; 2011 Jan; 10(1):10. PubMed ID: 21276221 [TBL] [Abstract][Full Text] [Related]
12. 3,5,4'-Trimethoxystilbene, a natural methoxylated analog of resveratrol, inhibits breast cancer cell invasiveness by downregulation of PI3K/Akt and Wnt/β-catenin signaling cascades and reversal of epithelial-mesenchymal transition. Tsai JH; Hsu LS; Lin CL; Hong HM; Pan MH; Way TD; Chen WJ Toxicol Appl Pharmacol; 2013 Nov; 272(3):746-56. PubMed ID: 23921149 [TBL] [Abstract][Full Text] [Related]
13. Epithelial requirement for in vitro proliferation and xenograft growth and metastasis of MDA-MB-468 human breast cancer cells: oncogenic rather than tumor-suppressive role of E-cadherin. Hugo HJ; Gunasinghe NPAD; Hollier BG; Tanaka T; Blick T; Toh A; Hill P; Gilles C; Waltham M; Thompson EW Breast Cancer Res; 2017 Jul; 19(1):86. PubMed ID: 28750639 [TBL] [Abstract][Full Text] [Related]
14. LincK contributes to breast tumorigenesis by promoting proliferation and epithelial-to-mesenchymal transition. Li J; Hao Y; Mao W; Xue X; Xu P; Liu L; Yuan J; Zhang D; Li N; Chen H; Zhao L; Sun Z; Luo J; Chen R; Zhao RC J Hematol Oncol; 2019 Feb; 12(1):19. PubMed ID: 30795783 [TBL] [Abstract][Full Text] [Related]
15. Fucoidan induces changes in the epithelial to mesenchymal transition and decreases metastasis by enhancing ubiquitin-dependent TGFβ receptor degradation in breast cancer. Hsu HY; Lin TY; Hwang PA; Tseng LM; Chen RH; Tsao SM; Hsu J Carcinogenesis; 2013 Apr; 34(4):874-84. PubMed ID: 23275155 [TBL] [Abstract][Full Text] [Related]
16. MCP-1-induced ERK/GSK-3β/Snail signaling facilitates the epithelial-mesenchymal transition and promotes the migration of MCF-7 human breast carcinoma cells. Li S; Lu J; Chen Y; Xiong N; Li L; Zhang J; Yang H; Wu C; Zeng H; Liu Y Cell Mol Immunol; 2017 Jul; 14(7):621-630. PubMed ID: 26996066 [TBL] [Abstract][Full Text] [Related]
17. Leptin promotes epithelial-mesenchymal transition of breast cancer via the upregulation of pyruvate kinase M2. Wei L; Li K; Pang X; Guo B; Su M; Huang Y; Wang N; Ji F; Zhong C; Yang J; Zhang Z; Jiang Y; Liu Y; Chen T J Exp Clin Cancer Res; 2016 Oct; 35(1):166. PubMed ID: 27769315 [TBL] [Abstract][Full Text] [Related]
18. Anti-EMT properties of CoQ0 attributed to PI3K/AKT/NFKB/MMP-9 signaling pathway through ROS-mediated apoptosis. Yang HL; Thiyagarajan V; Shen PC; Mathew DC; Lin KY; Liao JW; Hseu YC J Exp Clin Cancer Res; 2019 May; 38(1):186. PubMed ID: 31068208 [TBL] [Abstract][Full Text] [Related]
19. Long Non-Coding RNA (LncRNA) HOXA11-AS Promotes Breast Cancer Invasion and Metastasis by Regulating Epithelial-Mesenchymal Transition. Li W; Jia G; Qu Y; Du Q; Liu B; Liu B Med Sci Monit; 2017 Jul; 23():3393-3403. PubMed ID: 28701685 [TBL] [Abstract][Full Text] [Related]
20. Downregulation of β-catenin decreases the tumorigenicity, but promotes epithelial-mesenchymal transition in breast cancer cells. Cai K; Jiang L; Wang J; Zhang H; Wang X; Cheng D; Dou J J Cancer Res Ther; 2014; 10(4):1063-70. PubMed ID: 25579555 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]